Cargando…

Potential Role for the RASD1 Glucocorticoid-Responsive Gene in Corticotroph Tumorigenesis

Introduction: Originally identified due to its dexamethasone inducibility in mouse corticotropinoma AtT20 cells, RASD1 is a receptor-independent activator of G-proteins, via guanine nucleotide exchange factor (GEF) activity. It remains unclear, however, whether, and if so, how RASD1 mediates the eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernández-Ramírez, Laura C, Pankratz, Nathan, Lane, John, Hu, Mingming, Faucz, Fabio R, Chittiboina, Prashant, Denise, Kay M, Mills, James L, Stratakis, Constantine A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265992/ http://dx.doi.org/10.1210/jendso/bvab048.1118

Ejemplares similares

OR24-6 Non-syndromic Cushing's Disease Due To CDKN1B Mutations: Novel Mutations And Phenotypic Features In A Large Pediatric Cohort
por: Hernández-Ramírez, Laura, et al.
Publicado: (2019)

OR06-01 The Role of Germline Defects in Cushing’s Disease
por: Hernández-Ramírez, Laura C, et al.
Publicado: (2020)

RF01 | PMON167 Isolated Cushing's Disease Associated With Rare Germline SDHx Variants
por: Chittiboina, Prashant, et al.
Publicado: (2022)

OR2802 A Novel CABLES1 Missense Variant Associated With Cushing's Disease Disrupts Protein Structure And Stability
por: Franco-Álvarez, Alexa L, et al.
Publicado: (2023)

OR2803 Corticotroph Fate Weighted Cell Differentiation Paradigm For Human Induced Pluripotent Stem Cells
por: Elyse Moore, M, et al.
Publicado: (2023)

A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021)

OR23-01 Intrapatient ACTH Variability in Cushing’s Disease: Prognostic Significance
por: Alvarez, Reinier, et al.
Publicado: (2020)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

SAT-304 Pituitary Stem Cells May Drive Adenomas Causing Cushing’s Disease
por: Asuzu, David, et al.
Publicado: (2020)

MON-433 The Spectrum Of Growth Hormone Excess In Carney Complex: Characterizing A Common Finding In A Rare Syndrome
por: Tatsi, Christina, et al.
Publicado: (2019)

SAT-300 Evading Death: Noxa in Cushing’s Disease Pituitary Adenomas
por: Alvarez, Reinier, et al.
Publicado: (2020)

Clinical Correlation to E-cadherin and Granulation Patterns in Corticotroph Tumors
por: Lipe, Kristin A, et al.
Publicado: (2021)

Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

LBODP079 A Case of Silent Invasive Corticotroph Adenoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2022)

Co Existence of a Corticotroph Adenoma and a Multifunctional Pituitary Cyst
por: McDonnell, David John, et al.
Publicado: (2021)

ODP312 Giant Silent Corticotroph Adenoma: Presentation of 3 Cases
por: Oliveira, Miriam C, et al.
Publicado: (2022)

SAT618 Uncovering The Role Of O-glcnacylation In Pituitary Adenoma Pathogenesis: Insights From Corticotroph Tumors
por: Massman, Logan J, et al.
Publicado: (2023)

OR06-03 Serotonin Regulates Corticotroph Tumor Cell Proliferation and ACTH Secretion
por: Zhang, Dongyun, et al.
Publicado: (2020)

ODP301 Corticotroph Macroadenomas with Extensions to Third Ventricle: Four Case Reports
por: Suzuki, Yasuhiro, et al.
Publicado: (2022)

MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019)

SAT-311 Role of SREBP in Regulation of Corticotroph Tumor ACTH Secretion and Cell Proliferation
por: Zhang, Dongyun, et al.
Publicado: (2020)

New Transcriptional Insights into Silent and Active Corticotroph Pituitary Tumors at Single Cell Resolution
por: Zhang, Dongyun, et al.
Publicado: (2021)

PMON122 Unveiling the Kraken- An Incidentally Found Silent Corticotroph Adenoma of the Pituitary Gland
por: Shteyman, Sara, et al.
Publicado: (2022)

PI3K Inhibition by BKM120 Results in Antiproliferative Effects on Corticotroph Tumor Cells
por: Oliveira, Helen A, et al.
Publicado: (2021)

ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
por: Fukuoka, Hidenoi, et al.
Publicado: (2022)

OR23-04 SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors
por: castellnou, Solene, et al.
Publicado: (2020)

SAT-LB57 The Spectrum of Genomic and Transcriptomic Alterations in ACTH-Producing and ACTH-Silent Corticotroph Adenomas
por: Lerario, Antonio Marcondes, et al.
Publicado: (2020)

THU084 Corticotroph Tumor Type Influences Clinical Presentation In Patients With Nonfunctioning Pituitary Neuroendocrine Tumors
por: Al-Shamkhi, Nasrin, et al.
Publicado: (2023)

Neuromedin B Receptor Antagonist Suppresses Pomc Expression in AtT-20 Cells and Human Corticotroph Adenoma Cells
por: Sekizaki, Tomonori, et al.
Publicado: (2021)

ODP351 Silent Corticotroph Adenomas – Characteristics and Comparisons to Other Non-functioning Pituitary Adenomas: A Case Series
por: Di Ieva, Antonio, et al.
Publicado: (2022)

ODP338 Neuromedin B Receptor Antagonist Suppresses ACTH Secretion and Cell Proliferation in Human and Mouse Corticotroph Adenoma
por: Atsumi, Tatsuya, et al.
Publicado: (2022)

THU010 A Case Of Cushing(')s Disease Due To T-pit Positive, ACTH Negative Aggressive Corticotroph Pituitary Adenoma
por: Gopinath, Chaitra, et al.
Publicado: (2023)

ODP618 The profile of patients with ACTH-secreting pituitary adenomas and subclinical pituitary apoplexy
por: Tatsi, Christina, et al.
Publicado: (2022)

MON-468 Selective Inhibition of Epigenetic Pathways Has Anti-Proliferative and Pro-Apoptotic Effects on the Mouse Corticotroph Tumor Cells, AtT20
por: Lines, Kate, et al.
Publicado: (2019)

THU099 The Challenging Management Of Silent Corticotroph PitNET—From Very Aggressive To Mild Course Of Disease During Long Follow Up
por: Bogusławska, Anna, et al.
Publicado: (2023)

MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR
por: Reyes-Vidal, Carlos, et al.
Publicado: (2020)

Safety and Efficacy of Pegvisomant in Pediatric Growth Hormone Excess
por: Tatsi, Christina, et al.
Publicado: (2021)

SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice
por: Keil, Margaret, et al.
Publicado: (2020)

OR01-02 Epigenomic Dysregulation Of PPP1R17 Drives The Cell Cycle In Adenomas Causing Cushing’s Disease
por: Asuzu, David, et al.
Publicado: (2023)

SAT625 The EGF-TBX19-EGFR Positive Feedback Loop Regulates The Expression Of The CD44v9/SLC7A11 Antioxidant System Within Corticotroph Pituitary Neuroendocrine Tumors
por: Chakrabarti, Jayati, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d2n968pb31ab4bqj8sd2v6mcv8